Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation

Neuro-Oncology

Volumn 16, Issue 2, 2014, Pages 204-216

  Dell'Albani, Paola ^a   Rodolico, Margherita ^a   Pellitteri, Rosalia ^a   Tricarichi, Elisa ^a,b   Torrisi, Sebastiano Alfio ^a,b   D'Antoni, Simona ^a   Zappia, Mario ^b   Albanese, Vincenzo ^a,b   Caltabiano, Rosario ^b   Platania, Nunzio ^b   Aronica, Eleonora ^c,d   Catania, Maria Vincenza ^a,e  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^e OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

cell differentiation; gene expression; glioma cell cultures; gliomas; intermediate filaments; Notch receptors

Indexed keywords

CD133 ANTIGEN; GAMMA SECRETASE INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MTT ASSAY; NONHUMAN; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; WESTERN BLOTTING;

CELL DIFFERENTIATION; GENE EXPRESSION; GLIOMA CELL CULTURES; GLIOMAS; INTERMEDIATE FILAMENTS; NOTCH RECEPTORS;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM GRADING; PROTO-ONCOGENE PROTEINS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; RECEPTORS, NOTCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84893092792     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not168     Document Type: Article

References (37)

1. Kleihues P, CaveneeWK.Eds.World Health Organization Classificationof Tumors: Pathologyand Genetics of Tumors of the Nervous System. Lyon: IARC Press; 2000.
2. DellAlbani P. Stem cell markers in gliomas. Neurochem Res. 2008;33: 2407-2415.
3. Fleming RJ. Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol. 1998;9:599-607.
4. Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. Intracellular cleavage of notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281-291.
5. Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965-973.
6. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284: 770-776.
7. Tanigaki K, Nogaki F, Takahashi J, et al. Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron. 2001;29:45-55.
8. Morrison SJ, Perez SE, Qiao Z, et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 2000;101:499-510.
9. Hojo M, Ohtsuka T, Hashimoto N, et al. Glial cell fate specification modulated by the bHLH gene Hes5 in mouse retina. Development. 2000;127:2515-2522.
10. Gaiano N, Nye JS, Fishell G. Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron. 2000;26:395-404.
11. Stump G, Durrer A, Klein AL, et al. Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain. Mech Dev. 2002;114:153-159.
12. Irvin DK, Zurcher SD, Nguyen T, et al. Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development. J Comp Neurol. 2001;436:167-181.
13. Tanaka M, Kadokawa Y, Hamada Y, Marunouchi T. Notch2 expression negatively correlates with glial differentiation in the postnatal mouse brain. J Neurobiol. 1999;41:524-539.
14. Solecki DJ, Liu XL, Tomoda T, et al. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron. 2001;3:557-568.
15. Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologuemouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev. 1994;46(2): 123-136.
16. Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature,of CADASIL patients. J Clin Invest. 2000;105(5):597-605.
17. Uyttendaele H, Marazzi G, Wu G, et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996;122(7):2251-2259.
18. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumor suppressor? Nat Rev Cancer. 2003;3:756-767.
19. Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004;64: 7787-7793.
20. StockhausenMT, Kristoffersen K, Poulsen HS. Notch signaling and brain tumors. Adv Exp Med Biol. 2012;727:289-304.
21. Purow BW, Haque RM, Noel MW, et al. Expression of notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 2005;65:2353-2363.
22. Tchorz JS, Tome M, Cloetta D, et al. Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry. Cell Death Dis. 2012;3:e325.
23. BoulayJL, Miserez AR,Zweifel C, et al. Loss ofNOTCH2positively predicts survival in subgroups ofhumanglial braintumors. PLoSOne. 2007;2(6): e576.
24. Pierfelice TJ, Schreck KC, Dang L, et al. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res. 2011;71(3):1115-1125.
25. DellAlbani P, Santangelo R, Torrisi L, et al. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J Neurosci Res. 2001;65:417-424.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
27. Aronica E, Gorter JA, Redeker S, et al. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia. 2005;46:849-857.
28. Vandeputte DA, Troost D, Leenstra S, et al. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia. 2002; 38:329-338.
29. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsyassociated malformations of cortical development. Neurobiol Dis. 2006;24:128-143.
30. Bramanti V, Tomassoni D, Avitabile M, et al. Biomarkers of glial cell proliferation and differentiation in culture. Front Biosci (Schol Ed). 2010;2:558-570.
31. Reis RM, Konu-Lebleblicioglu D, Lopes JM, et al. Genetic profile of gliosarcomas. Am J Pathol. 2000;156:425-432.
32. Coowar D, Bouissac J, Hanbali M, et al. Effects of indole fatty alcoholson the differentiation of neural stem cell derived neurospheres. Med Chem. 2004;47(25):6270-6282.
33. Cheung HC, Corley LJ, Fuller GN, et al. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol. 2006;19(8):1034-1041.
34. PhillipsHS,KharbandaS,ChenR,etal.Molecular subclassesofhigh-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157-173.
35. Li J, Cui Y, Gao G, et al. Notch1 is an independent prognostic factor for patients with glioma. J Surg Oncol. 2011;103(8):813-817.
36. Xu P, Zhang A, Jiang R, et al. The different role of Notch1 and Notch2 in astrocytic gliomas. PLoS One. 2013;8(1):e53654.
37. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development. 2007; 134:1243-1251.